Last $10.34 USD
Change Today +0.14 / 1.37%
Volume 171.1K
XNCR On Other Exchanges
Symbol
Exchange
NASDAQ GM
Munich
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

xencor inc (XNCR) Snapshot

Open
$10.16
Previous Close
$10.20
Day High
$10.88
Day Low
$10.16
52 Week High
03/14/14 - $14.41
52 Week Low
12/3/13 - $5.75
Market Cap
324.3M
Average Volume 10 Days
153.8K
EPS TTM
--
Shares Outstanding
31.4M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for XENCOR INC (XNCR)

Related News

No related news articles were found.

xencor inc (XNCR) Related Businessweek News

No Related Businessweek News Found

xencor inc (XNCR) Details

Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs. It develops its antibody product candidates to treat autoimmune and allergic diseases, cancer, and other conditions through its proprietary XmAb technology platform. The company’s lead XmAb-engineered antibodies include XmAb5871, a B-cell inhibitor, which is in Phase Ib/IIa clinical trials for the treatment of autoimmune diseases, such as rheumatoid arthritis and lupus; XmAb7195, an IgE inhibitor under Phase Ib clinical trial initiation to treat asthma and allergic diseases; and XmAb5574/MOR208, a Cytotoxic B-cell depleting product candidate that is in Phase II clinical trials for the treatment of B-cell cancers. It has a collaboration agreement with Boehringer Ingelheim International GmbH; and development and manufacturing services agreement with Catalent Pharma Solutions LLC. The company was founded in 1997 and is based in Monrovia, California.

28 Employees
Last Reported Date: 03/31/14
Founded in 1997

xencor inc (XNCR) Top Compensated Officers

Co-Founder, Chief Executive Officer, Presiden...
Total Annual Compensation: $358.8K
Chief Medical Officer
Total Annual Compensation: $402.0K
Chief Business Officer
Total Annual Compensation: $286.1K
Compensation as of Fiscal Year 2012.

xencor inc (XNCR) Key Developments

Xencor, Inc.(NasdaqGM:XNCR) added to Russell 2000 Index

Xencor, Inc. will be added to the Russell 2000 Index.

Xencor, Inc.(NasdaqGM:XNCR) added to Russell 3000 Index

Xencor, Inc. will be added to the Russell 3000 Index.

Xencor, Inc. Announces Board Changes

Harold R. Werner notified Xencor, Inc. of his resignation from the board of directors of the company, effective immediately. To fill the vacancies created by Mr. Werner’s resignation, the Board appointed Dr. Bruce L.A. Carter, one of its existing directors, as a member of the Audit Committee of the Board and as chairman of the Compensation Committee of the Board and Robert F. Baltera, Jr., one of its existing directors, as a member of the Nominating and Corporate Governance Committee of the Board.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
XNCR:US $10.34 USD +0.14

XNCR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for XNCR.
View Industry Companies
 

Industry Analysis

XNCR

Industry Average

Valuation XNCR Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact XENCOR INC, please visit www.xencor.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.